NASDAQ: NGNENeurogene Inc Stock Ownership - Who owns Neurogene?
Insider buying vs selling
Have Neurogene Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Rachel McMinn | Chief Executive Officer | 2026-03-26 | 3,352 | $22.08 | $74.00kSell |
| Julie Jordan | Chief Medical Officer | 2026-03-26 | 828 | $21.89 | $18.13kSell |
| Christine Mikail Cvijic | President and CFO | 2026-03-26 | 2,558 | $21.63 | $55.32kSell |
| Stuart Cobb | Chief Scientific Officer | 2026-03-13 | 148 | $22.08 | $3.27kSell |
| Christine Mikail Cvijic | President and CFO | 2026-03-13 | 1,395 | $21.25 | $29.64kSell |
| Christine Mikail Cvijic | President and CFO | 2026-03-13 | 263 | $22.02 | $5.79kSell |
| Christine Mikail Cvijic | President and CFO | 2026-03-13 | 2,387 | $20.42 | $48.75kSell |
| Stuart Cobb | Chief Scientific Officer | 2026-03-13 | 3,991 | $20.41 | $81.46kSell |
| Stuart Cobb | Chief Scientific Officer | 2026-03-13 | 2,658 | $21.34 | $56.72kSell |
| Christine Mikail Cvijic | President and CFO | 2026-02-27 | 4,800 | $25.11 | $120.53kSell |
NGNE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when NGNE insiders and whales buy or sell their stock.
NGNE Shareholders
What type of owners hold Neurogene Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Redmile Group LLC | 24.83% | 3,866,579 | $107.68M | Insider |
| Jonathan G. Drachman | 14.76% | 2,298,686 | $64.02M | Insider |
| Gary Bridger | 12.35% | 1,922,775 | $53.55M | Insider |
| Samsara Biocapital LLC | 11.03% | 1,717,127 | $47.82M | Institution |
| Samsara Biocapital GP LLC | 10.71% | 1,668,357 | $46.46M | Insider |
| Ventures West 8 Limited Partnership | 9.91% | 1,543,989 | $43.00M | Insider |
| Redmile Group LLC | 9.37% | 1,459,599 | $40.65M | Institution |
| Johnson Johnson | 9.26% | 1,442,094 | $40.16M | Insider |
| Rtw Investments LP | 8.75% | 1,362,456 | $37.94M | Institution |
| Carl Walkey | 8.68% | 1,352,489 | $37.67M | Insider |
NGNE vs Biotech Stocks
Neurogene Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.